恶性肿瘤与血栓性疾病

被引:69
作者
王惠杰
张湘茹
机构
[1] 中国医学科学院中国协和医科大学肿瘤医院内科
关键词
恶性肿瘤; 血栓性疾病;
D O I
暂无
中图分类号
R730.7 [预后];
学科分类号
100214 ;
摘要
血栓栓塞性疾病是恶性肿瘤疾病过程中常见的并发症,其存在与肿瘤本身的进展、治疗及预后密切相关。本文对恶性肿瘤伴血栓栓塞性疾病的发生机制、危险因素、预防、治疗,抗凝/抗栓治疗的现状及对肿瘤预后的影响进行回顾。
引用
收藏
页码:39 / 46
页数:8
相关论文
共 33 条
[1]  
Prospective evaluation of major vascular eventsin patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine. Numico G,Garrone O,Dongiovanni V,et al. Cancer . 2005
[2]  
DVTFREE Steering Committee.A prospective registry of5,451patients with ultrasound-con-firmed deep vein thrombosis. Goldhaber SZ,Tapson VF. The American Journal of Cardiology . 2004
[3]  
Management of thrombosis in the cancer patient. Andrea N,Ansell J. J Suppo Oncol . 2003
[4]  
Bevacizumab plus irinotecan,fluorouracil,and leucovorin for metastatic colorectal cancer. Hurwitz H,Fehrenbacher L,Novotny W,et al. The New England Journal of Medicine . 2004
[5]  
Double-blind random-isedtrial of a very-low-dose warfarinfor prevention of throm-boembolismin stageⅣbreast cancer. Levine M,Hirsh J,Gent M,et al. The Lancet . 1994
[6]  
Search for occult malignancyin patients with deep venous thrombosis.Re-sults of a retrospective cohort study. Ronsdorf A,Perruchoud AP,Schoenenberger RA. Swiss Medical Weekly . 2003
[7]  
Venous thromboembolismassociated with long-termuse of central venous catheters in cancer patients. Verso M,Agnelli G. Journal of Clinical Oncology . 2003
[8]  
Markers of coagulation and angiogenesisin cancer-associated venousthromboembolism. Goldenberg N,Kahn SR,Solymoss S. Journal of Clinical Oncology . 2003
[9]  
Aclinical trial of vena caval filters inthe prevention of pulmonary embolismin patients with proximal deep-vein thrombosis. Decousus H,Leizorovicz A,Parent F. The New England Journal of Medicine . 1998
[10]  
Arandomized com-parison of lowmolecular weight heparin and coumarin derivatives onthe survival of patients with cancer and venousthromboembo-lism. Lee AYY,Rickles FR,Julian JA,et al. Journal of Clinical Oncology . 2005